| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| RBMXL1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402165 | 1 kit | ORIGENE TECHNOLOGIES |
| RBMXL2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409234 | 1 kit | ORIGENE TECHNOLOGIES |
| RBMXL3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN427399 | 1 kit | ORIGENE TECHNOLOGIES |
| Rbmxl1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN514588 | 1 kit | ORIGENE TECHNOLOGIES |
| Rbmxl2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN514589 | 1 kit | ORIGENE TECHNOLOGIES |
| RBMY1A1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408402 | 1 kit | ORIGENE TECHNOLOGIES |
| RBMY1B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418579 | 1 kit | ORIGENE TECHNOLOGIES |
| RBMY1D - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418382 | 1 kit | ORIGENE TECHNOLOGIES |
| RBMY1E - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN413726 | 1 kit | ORIGENE TECHNOLOGIES |
| RBMY1F - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406038 | 1 kit | ORIGENE TECHNOLOGIES |
| RBMY1J - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN412464 | 1 kit | ORIGENE TECHNOLOGIES |
| Rbm31y - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN514564 | 1 kit | ORIGENE TECHNOLOGIES |
| T cell immunoreceptor with Ig and ITIM domains (TIGIT) from ORIGENE TECHNOLOGIES | LY406575 | 100 ug | ORIGENE TECHNOLOGIES |
| T cell-interacting, activating receptor on myeloid cells 1 (TARM1) from ORIGENE TECHNOLOGIES | LY427668 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia homeobox 1 (TLX1) from ORIGENE TECHNOLOGIES | LY417248 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia homeobox 3 (TLX3) from ORIGENE TECHNOLOGIES | LY412148 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 1A (TCL1A), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411851 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 1A (TCL1A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420669 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 1A (TCL1A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426041 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 1B (TCL1B), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417659 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 1B (TCL1B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404695 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 1B (TCL1B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430802 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 6 (TCL6), transcript variant TCL6a1 from ORIGENE TECHNOLOGIES | LY415738 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 6 (TCL6), transcript variant TCL6a1 from ORIGENE TECHNOLOGIES | LY429370 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 6 (TCL6), transcript variant TCL6a2 from ORIGENE TECHNOLOGIES | LY415292 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 6 (TCL6), transcript variant TCL6a2 from ORIGENE TECHNOLOGIES | LY429422 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia/lymphoma 6 (TCL6), transcript variant TCL6a3 from ORIGENE TECHNOLOGIES | LY412420 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell leukemia translocation altered gene (TCTA) from ORIGENE TECHNOLOGIES | LY411726 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell lymphoma invasion and metastasis 1 (TIAM1) from ORIGENE TECHNOLOGIES | LY418807 | 100 ug | ORIGENE TECHNOLOGIES |
| T-cell lymphoma invasion and metastasis 2 (TIAM2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423235 | 100 ug | ORIGENE TECHNOLOGIES |
| T cell receptor associated transmembrane adaptor 1 (TRAT1) from ORIGENE TECHNOLOGIES | LY413992 | 100 ug | ORIGENE TECHNOLOGIES |
| TCERG1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217192 | 1 kit | ORIGENE TECHNOLOGIES |
| TCERG1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217192BN | 1 kit | ORIGENE TECHNOLOGIES |
| TCERG1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217192LP | 1 kit | ORIGENE TECHNOLOGIES |
| TCERG1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN217192RB | 1 kit | ORIGENE TECHNOLOGIES |
| TCERG1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417192 | 1 kit | ORIGENE TECHNOLOGIES |
| Tcerg1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN517316 | 1 kit | ORIGENE TECHNOLOGIES |
| Fstl5 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506158 | 1 kit | ORIGENE TECHNOLOGIES |
| FSTL1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300586 | 10 ug | ORIGENE TECHNOLOGIES |
| FSTL3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300811 | 10 ug | ORIGENE TECHNOLOGIES |
| FSTL4 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH319694 | 10 ug | ORIGENE TECHNOLOGIES |
| FST Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH315777 | 10 ug | ORIGENE TECHNOLOGIES |
| FST Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302523 | 10 ug | ORIGENE TECHNOLOGIES |
| FTCD - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408573 | 1 kit | ORIGENE TECHNOLOGIES |
| Ftcd - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506159 | 1 kit | ORIGENE TECHNOLOGIES |
| FTCD Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH308573 | 10 ug | ORIGENE TECHNOLOGIES |
| Fth1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506160 | 1 kit | ORIGENE TECHNOLOGIES |
| FTH1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409845 | 1 kit | ORIGENE TECHNOLOGIES |
| Fthl17a - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN500048 | 1 kit | ORIGENE TECHNOLOGIES |
| Fthl17d - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506703 | 1 kit | ORIGENE TECHNOLOGIES |